Newsroom

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Moderate Buffer UCITS ETF - November 08.09.2026 GNOV LN IE000OJ31JQ4  950,002.00 USD  35,759,133.61   37.641  ...

PALO ALTO, Calif.--(BUSINESS WIRE)--Ridge Biotechnologies (Ridge Bio), a biotechnology company pioneering enzyme and conditionally-activated drug design to power the next wave of precision therapeutics, today announced additional investment, bringing capital raised to approximately $38M. The upsized seed round was anchored by Dimension Capital, joining founding investor Sutter Hill Ventures (SHV), which incubated the company prior to its launch in the fall of last year, and Overlap Holdings, wh...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Moderate Buffer UCITS ETF- August 08.09.2026 GAUG LN IE000TGSG3Y5  700,002.00 USD  26,385,720.45   37.694  ...

BOSTON--(BUSINESS WIRE)--Henry Ford Health partners with I-PASS to implement structured handoff communication across 11 hospitals, strengthening patient safety statewide....

DENVER--(BUSINESS WIRE)--NUBURU, Inc. (OTC Pink: BURUD) (“NUBURU” or the “Company”), a next-generation dual-use Defense & Security integrated platform company, today announced that, following notification from NYSE Regulation, trading in the Company’s common stock is scheduled to resume on NYSE American on Monday, September 14, 2026, under the ticker symbol “BURU.” The Company’s common stock will continue to use CUSIP number 67021W509. The resumption follows NUBURU’s 1-for-40 reverse stock...

SINGAPORE--(BUSINESS WIRE)--Seagate Technology Holdings plc (NASDAQ: STX) (“Seagate” or “Company”) and Seagate HDD Cayman, a subsidiary of Seagate (“Seagate HDD”) today announced that Seagate HDD has settled all redemptions and exchanges of the remaining approximately $150.7 million principal amount of Seagate HDD’s 3.50% Exchangeable Senior Notes due 2028 (the “notes”). On September 8, 2026 (the “redemption date”), all then-outstanding notes that were called for redemption and were not submitt...

MUMBAI, India--(BUSINESS WIRE)--LTM today announced that it has collaborated with IBM and Red Hat on Lightwell to advance AI-driven open-source software remediation....

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Crossbow dosed the first participant in its Phase 1 clinical trial of CBX-663, for the treatment of multiple hematologic and solid tumors....

GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx and Beren Therapeutics Launch NPC GenomeComplete to Improve Diagnosis of Niemann-Pick Disease Type C...

FLORHAM PARK, N.J.--(BUSINESS WIRE)--Shionogi Inc., a New Jersey-based subsidiary of Shionogi & Co., Ltd., (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.), will present findings from across its broad anti-infective portfolio at IDWeek 2026 (October 21-24, 2026), in Washington, D.C. Data highlights at IDWeek 2026 include an oral presentation featuring a subpopulation analysis from the global Phase 3 SCORPIO-PEP trial, a rapid-fire session focused on ventilator-ass...